Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma

  1. Mateos, M.-V.
  2. Chari, A.
  3. Usmani, S.Z.
  4. Goldschmidt, H.
  5. Weisel, K.
  6. Qi, K.
  7. Londhe, A.
  8. Nair, S.
  9. Lin, X.
  10. Pei, L.
  11. Ammann, E.
  12. Kobos, R.
  13. Smit, J.
  14. Parekh, T.
  15. Marshall, A.
  16. Slavcev, M.
  17. Moreau, P.
Revue:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2669 2152-2650

Année de publication: 2023

Volumen: 23

Número: 5

Pages: 385-393

Type: Article

DOI: 10.1016/J.CLML.2023.02.006 GOOGLE SCHOLAR

Objectifs de Développement Durable